● TIER 3 — Information onlyGRADE C/B-Immune / thymic
Imunofan (Arg-α-Asp-Lys-Val-Tyr-Arg) [NEW]
Origin: Russia. Citations verified: partial. 1 human study record(s) in the FitClinicMD studies database.
FDA status
Not an FDA-approved product
Compounding (503A/503B)
Status varies — see notes
DEA
Not listed as controlled
WADA (sport)
Not specified
Mechanism
Synthetic hexapeptide (thymopoietin fragment-derived) immunomodulator 1.
Human evidence · 1
Imunofan in T2D patients with diabetic foot syndrome.
other/unspecifiedPMID 20481041 →
Reference only. This page summarizes publicly available regulatory and research information about Imunofan (Arg-α-Asp-Lys-Val-Tyr-Arg) [NEW]. It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.